Obesity impacts the expression of Alzheimer's disease–related genes: The Framingham Heart Study

Sokratis Charisis, Honghuang Lin, Roshni Ray, Roby Joehanes, Alexa S. Beiser, Daniel Levy, Sudha Seshadri, Muralidharan Sargurupremraj, Claudia L. Satizabal

Producción científica: Articlerevisión exhaustiva

6 Citas (Scopus)


INTRODUCTION: We investigated associations of obesity with the expression of Alzheimer's disease (AD)–related genes in a large community-based cohort. METHODS: The sample consisted of 5619 participants from the Framingham Heart Study. Obesity metrics included body mass index (BMI) and waist-to-hip ratio (WHR). Gene expression was measured for a set of 74 AD-related genes, derived by integrating genome-wide association study results with functional genomics data. RESULTS: Obesity metrics were associated with the expression of 21 AD-related genes. The strongest associations were observed with CLU, CD2AP, KLC3, and FCER1G. Unique associations were noted with TSPAN14, SLC24A4 for BMI, and ZSCAN21, BCKDK for WHR. After adjustment for cardiovascular risk factors, 13 associations remained significant for BMI and 8 for WHR. Dichotomous obesity metrics exhibited unique associations with EPHX2 for BMI, and with TSPAN14 for WHR. DISCUSSION: Obesity was associated with AD-related gene expression; these findings shed light on the molecular pathways linking obesity to AD.

Idioma originalEnglish (US)
Páginas (desde-hasta)3496-3505
Número de páginas10
PublicaciónAlzheimer's and Dementia
EstadoPublished - ago 2023

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health


Profundice en los temas de investigación de 'Obesity impacts the expression of Alzheimer's disease–related genes: The Framingham Heart Study'. En conjunto forman una huella única.

Citar esto